ロード中...
Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
BACKGROUND: Late-life depression is a common, chronic and recurring disorder for which guidelines recommend long-term therapy. The safety and efficacy of duloxetine for the treatment of major depressive disorder (MDD) were evaluated using data from elderly patients (age ≥ 65 years; n = 101) who part...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2004
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC544561/ https://ncbi.nlm.nih.gov/pubmed/15585058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2318-4-11 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|